心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2021 EACVI专家共识：多模式成像在射血分数保留心衰患者中的应用

2021-11-03 欧洲协会心血管影像协会 Eur Heart J Cardiovasc Imaging

射血分数保留心力衰竭影像及腔内体外循环

2021年11月，欧洲协会心血管影像协会(EACVI)发布了多模式成像在射血分数保留心衰患者中的应用共识。几乎半数的心力衰竭（HF）患者的左室射血分数（EF)正常，称为射血分数保留心衰（HFpEF）。

中文标题：

2021 EACVI专家共识：多模式成像在射血分数保留心衰患者中的应用

英文标题：

Multimodality imaging in patients with heart failure and preserved ejection fraction: an expert consensus document of the European Association of Cardiovascular Imaging

发布机构：

欧洲协会心血管影像协会

发布日期：

2021-11-03

简要介绍：

2021年11月，欧洲协会心血管影像协会(EACVI)发布了多模式成像在射血分数保留心衰患者中的应用共识。几乎半数的心力衰竭（HF）患者的左室射血分数（EF)正常，称为射血分数保留心衰（HFpEF）。本文主要针对HFpEF患者的多模式成像检查的应用提供共识指导。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 EACVI专家共识：多模式成像在射血分数保留心衰患者中的应用.pdf)] GetToolGuiderByIdResponse(projectId=1, id=8f7cb1c002253236, title=2021 EACVI专家共识：多模式成像在射血分数保留心衰患者中的应用, enTitle=Multimodality imaging in patients with heart failure and preserved ejection fraction: an expert consensus document of the European Association of Cardiovascular Imaging, guiderFrom=Eur Heart J Cardiovasc Imaging, authorId=0, author=, summary=2021年11月，欧洲协会心血管影像协会(EACVI)发布了多模式成像在射血分数保留心衰患者中的应用共识。几乎半数的心力衰竭（HF）患者的左室射血分数（EF)正常，称为射血分数保留心衰（HFpEF）。, cover=https://img.medsci.cn/2021114/1636010966155_1608702.jpg, journalId=0, articlesId=null, associationId=1080, associationName=欧洲协会心血管影像协会, associationIntro=null, copyright=0, guiderPublishedTime=Wed Nov 03 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年11月，欧洲协会心血管影像协会(EACVI)发布了多模式成像在射血分数保留心衰患者中的应用共识。几乎半数的心力衰竭（HF）患者的左室射血分数（EF)正常，称为射血分数保留心衰（HFpEF）。本文主要针对HFpEF患者的多模式成像检查的应用提供共识指导。</span></p>, tagList=[TagDto(tagId=70875, tagName=射血分数保留心力衰竭), TagDto(tagId=117081, tagName=影像及腔内体外循环)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=40, categoryName=影像放射, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=52059, guiderKeyword=射血分数保留性心力衰竭, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3426, appHits=60, showAppHits=0, pcHits=288, showPcHits=3366, likes=1, shares=6, comments=3, approvalStatus=1, publishedTime=Tue Nov 16 23:56:36 CST 2021, publishedTimeString=2021-11-03, pcVisible=1, appVisible=1, editorId=1614372, editor=MedSciZeng, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=dajiong, createdTime=Thu Nov 04 15:35:49 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Fri Jan 05 11:49:00 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 EACVI专家共识：多模式成像在射血分数保留心衰患者中的应用.pdf)])
2021 EACVI专家共识：多模式成像在射血分数保留心衰患者中的应用.pdf
下载请点击：
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1074184, encodeId=379110e418412, content=不错 学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Fri Nov 26 14:04:33 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068261, encodeId=c8e01068261e4, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9115699431, createdName=ms3000002011741948, createdTime=Mon Nov 08 20:51:46 CST 2021, time=2021-11-08, status=1, ipAttribution=)]
    2021-11-26 H8888888

    不错 学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1074184, encodeId=379110e418412, content=不错 学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Fri Nov 26 14:04:33 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068261, encodeId=c8e01068261e4, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9115699431, createdName=ms3000002011741948, createdTime=Mon Nov 08 20:51:46 CST 2021, time=2021-11-08, status=1, ipAttribution=)]
    2021-11-08 ms3000002011741948

    很好

    0